David R. Spigel, MD

Chief Scientific Officer; Director
Lung Cancer Research Program
Sarah Cannon Research Institute
Nashville, TN
Authored Items
Exciting New Data Presented on NSCLC at AACR 2021
David R. Spigel, MD
June 19, 2021 | Conference Correspondent
Dr David Spigel discusses key presentations on immunotherapy and targeted therapy in the neoadjuvant and adjuvant settings in NSCLC.
Combination Therapies and New Molecular Targets—Presentations from AACR 2021
David R. Spigel, MD
June 19, 2021 | Conference Correspondent
Dr David Spigel reviews potentially practice-changing data on EGFR-TKI combination therapies in NSCLC, new approaches to advanced NSCLC and CNS involvement, and hopeful early data with novel targeted agents.
Finding Lung Cancer in the Dark…Utilizing Technology to Help Us Identify Early-Stage Lung Cancer
Tammy Baxter, MD, Brook Blackmore, MSN, RN, Howard A. Burris, MD, Melissa L. Johnson, MD, Sharon Moore, RN, Priscilla Smith, RN, David R. Spigel, MD
September 23, 2016 | October 2016 Vol 7, No 9
This work indicates that the use of technology can improve diagnosis of early-stage lung cancer in the ER setting within the general population.
Last modified: June 22, 2021

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State

    Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code
    Country
     
SUBSCRIBE

Contact Us | Editorial Board

© 2009-2021 DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512